| scholarly article | Q13442814 |
| P2093 | author name string | Chessells JM | |
| P2860 | cites work | Remission death in acute lymphoblastic leukaemia: a changing pattern | Q33624032 |
| Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? | Q35187800 | ||
| Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia | Q35603604 | ||
| Importance of 6-mercaptopurine dose in lymphoblastic leukaemia | Q35626568 | ||
| The modulation of radiation-induced damage to pig skin by essential fatty acids | Q35976354 | ||
| The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia | Q35992880 | ||
| Results and significance of six randomized trials in four consecutive ALL-BFM studies | Q37913555 | ||
| Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance | Q40611759 | ||
| Childhood acute lymphocytic leukemia. Study VIII | Q40964732 | ||
| Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis | Q41762709 | ||
| Physician compliance and relapse rates of acute lymphoblastic leukemia in children | Q48106955 | ||
| A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results | Q48216598 | ||
| Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia | Q48300032 | ||
| Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group | Q48710966 | ||
| Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy | Q68289938 | ||
| Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia | Q68323379 | ||
| Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia | Q69386555 | ||
| Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study | Q69724889 | ||
| Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia | Q69926243 | ||
| Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood) | Q70219983 | ||
| Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology | Q71671957 | ||
| Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia | Q72676651 | ||
| The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia | Q72823593 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 368-373 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | Maintenance treatment and shared care in lymphoblastic leukaemia | |
| P478 | volume | 73 |
| Q33930802 | Recent advances in management of acute leukaemia | cites work | P2860 |
Search more.